Our Strategies


ArrowMark’s actively managed equity strategies focus on market segments and industries where our time-tested fundamental research investment process, specialized expertise, and long-term perspective offer the potential to gain a distinct competitive advantage.

We manage several U.S. small and SMID cap equity strategies, along with a hedged equity strategy, which follow a similar philosophy rooted in constructing high-quality portfolios with an emphasis on downside risk mitigation. We also manage a private life science strategy that follows a science-driven process to identify early- to late-stage private and public life science companies innovating revolutionary drugs and treatment therapies to advance the standard of medical care and quality of patient life.

Equity Statistics

As of 3/31/2024